Outset Medical, INC Form 4 insider transactions

Outset Medical's EVP of R&D, Operations and Service, Marc Nash, was granted 5,617 restricted stock units.

Outset Medical's Chair and CEO, Leslie Trigg, sold 904 shares of common stock to cover tax withholding obligations related to RSU vesting.

Outset Medical's SVP of Operations and R&D, Marc Nash, sold 243 shares of common stock to cover tax withholding obligations related to RSU vesting.

Outset Medical's General Counsel, John L. Brottem, sold 383 shares of common stock to cover tax withholding obligations related to RSU vesting.

Outset Medical, Inc. SVP of Operations and R&D, Marc Nash, was granted 29,676 restricted stock units (RSUs) on June 10, 2025, as part of his compensation.

Outset Medical, Inc.'s General Counsel, John L. Brottem, has reported the acquisition of 35,993 Restricted Stock Units (RSUs) as part of his compensation.

Outset Medical, Inc.'s Chair and CEO, Leslie Trigg, was granted 65,103 restricted stock units (RSUs) on June 10, 2025, as reported in a recent SEC Form 4 filing.

Outset Medical, Inc.'s Chief Financial Officer, Renee Gaeta, was granted 131,425 restricted stock units (RSUs) on June 10, 2025, aligning her interests with long-term shareholder value.

Outset Medical, Inc. Director Andrea Lynn Saia was granted 8,983 Restricted Stock Units (RSUs) on June 2, 2025, with vesting tied to a one-year anniversary or the next Annual Meeting of Stockholders, following a 1-for-15 reverse stock split enacted in March 2025.

Outset Medical, Inc. Director Kevin C. O'Boyle has been granted 8,983 shares of common stock in the form of Restricted Stock Units (RSUs), increasing his direct beneficial ownership to 24,118 shares.

Outset Medical, Inc. Director Brent D. Lang reported the acquisition of 8,983 shares of common stock through a Restricted Stock Unit (RSU) grant, with his total beneficial ownership adjusted for a recent 1-for-15 reverse stock split.

Outset Medical, Inc. Director Patrick T. Hackett reported the acquisition of 8,983 shares of common stock through a Restricted Stock Unit (RSU) grant, increasing his total beneficial ownership to 95,172 direct shares.

Outset Medical, Inc. Director D. Keith Grossman reported the acquisition of 8,983 shares of common stock on June 2, 2025, primarily through a Restricted Stock Unit grant, as disclosed in a recent SEC Form 4 filing.

Outset Medical Director Karen Drexler was granted 8,983 shares of common stock, with vesting tied to the one-year anniversary of the grant or the next Annual Meeting of Stockholders, following a recent 1-for-15 reverse stock split.

Leslie Trigg, Chair and CEO of Outset Medical, sold 935 shares of common stock on May 15, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 252 shares of common stock to cover tax withholding obligations related to vesting RSUs.

John L. Brottem, General Counsel of Outset Medical, Inc., sold 396 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Nabeel Ahmed, CFO of Outset Medical, sold 584 shares of common stock on May 15, 2025, to cover tax withholding obligations related to vesting RSUs.

Director Kevin O'Boyle of Outset Medical, Inc. was granted 15,135 Restricted Stock Units (RSUs) on May 14, 2025, which vest quarterly over three years.

Leslie Trigg, Chair and CEO of Outset Medical, reports the conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock following stockholder approval on March 5, 2025.

Director Brent D. Lang converted Series A Non-Voting Convertible Preferred Stock into Common Stock of Outset Medical, Inc. following stockholder approval.

Director Karen Drexler converted Series A Non-Voting Convertible Preferred Stock into Common Stock of Outset Medical, Inc. following stockholder approval.

D Keith Grossman, a director of Outset Medical, Inc., reports the conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock following stockholder approval.

Director Patrick Hackett reports the conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock following stockholder approval on March 5, 2025.

Leslie Trigg, Chair and CEO of Outset Medical, sold 14,611 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Marc Nash, SVP Operations and R&D at Outset Medical, sold 4,204 shares of common stock to cover tax withholding obligations related to vesting RSUs.

John L. Brottem, General Counsel of Outset Medical, sold 6,145 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Nabeel Ahmed, CFO of Outset Medical, sold 8,659 shares of common stock to cover tax withholding obligations related to vesting RSUs.

Outset Medical's CEO, Leslie Trigg, executed several stock transactions, including the acquisition of performance-based restricted stock units and sales to cover tax obligations, following the vesting of performance-based units.

Outset Medical's SVP of Operations and R&D, Marc Nash, reports the acquisition and sale of company stock following the vesting of performance-based restricted stock units.